Dr. Merlyn Lucas is Associate Director, Pharmaceutical Clinical Development, VMRD for Pfizer Animal Health. At the recent Pfizer media event he spoke to us about some of his research that focused on single-dose therapy, specifically on Excede and Draxxin. These products are used to treat cattle for bovine respiratory disease.

He says that producers are starting to learn that these products have really changed their need to treat cattle frequently. In fact, the research he’s done makes it pretty clear that waiting to re-treat cattle after using these products is cost effective. Who doesn’t want to save some money?

You can listen to my interview with Dr. Lucas here: pfizer-vmrd-07-lucas.mp3

Or if you’d like you can download it here: Dr. Merlyn Lucas Interview